Results 31 to 40 of about 21,170 (204)

CD203c is expressed by human fetal hepatoblasts and distinguishes subsets of hepatoblastoma

open access: yesFrontiers in Oncology, 2023
Background & AimsHepatocytic cells found during prenatal development have unique features compared to their adult counterparts, and are believed to be the precursors of pediatric hepatoblastoma.
Marcus O. Muench   +13 more
doaj   +1 more source

Surgical treatment of childhood hepatoblastoma in the Netherlands (1990–2013) [PDF]

open access: yes, 2017
Background: Achievement of complete surgical resection plays a key role in the successful treatment of children with hepatoblastoma. The aim of this study is to assess the surgical outcomes after partial liver resections for hepatoblastoma, focusing on ...
Bakx, R. (Roel)   +8 more
core   +1 more source

Insulin-like growth factor binding protein-5 as a biomarker for detection of early liver disease [PDF]

open access: yes, 2011
Study identifying an Insulin-like growth factor binding protein-5 as a biomarker for detection of early liver disease presented at the annual congress of the british toxicology ...
Anne Pryde   +9 more
core   +1 more source

Malignant hypertension secondary to renin-producing hepatoblastoma

open access: yesIndian Journal of Medical and Paediatric Oncology, 2020
Clinical presentation of hepatoblastoma is often insidious and its paraneoplastic manifestations are not uncommon. We report an extremely rare case of a renin-secreting hepatoblastoma inducing malignant hypertension remarked in our clinic.
Doinita Sfrijan   +3 more
doaj   +1 more source

Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials. [PDF]

open access: yes, 2018
Cisplatin is an essential chemotherapeutic agent in the treatment of many pediatric cancers. Unfortunately, cisplatin-induced hearing loss (CIHL) is a common, clinically significant side effect with life-long ramifications, particularly for young ...
Chang, Kay   +9 more
core   +1 more source

Circ-CCT2 Activates Wnt/β-catenin Signaling to Facilitate Hepatoblastoma Development by Stabilizing PTBP1 mRNASummary

open access: yesCellular and Molecular Gastroenterology and Hepatology
Background & Aims: Circ-CCT2 (hsa_circ_0000418) is a novel circular RNA that stems from the CCT2 gene. However, the expression of circ-CCT2 and its roles in hepatoblastoma are unknown.
Qin Zhu   +5 more
doaj   +1 more source

Congenital hepatoblastoma presenting with hepatic arteriovenous fistulas: a case report

open access: yesFrontiers in Pediatrics, 2023
AimCongenital hepatoblastoma, a rare malignant liver tumor in infancy, typically presents with abdominal distension or mass. Tumors detected antenatally or during the first three months of age are considered congenital hepatoblastoma.
Jiao Lin   +5 more
doaj   +1 more source

The paradox of cancer genes in non-malignant conditions: implications for precision medicine. [PDF]

open access: yes, 2020
Next-generation sequencing has enabled patient selection for targeted drugs, some of which have shown remarkable efficacy in cancers that have the cognate molecular signatures.
Adashek, Jacob J   +3 more
core  

Hepatoblastoma and microRNA-483 two forms and one outcome [PDF]

open access: yes, 2016
Hepatoblastoma (HB) is the most common liver cancer in infants younger than 3 years. Its onset has been associated with other genetic syndromes and some genetic and biochemical markers has been identified recently in this neoplasia.
Basso, E.   +7 more
core   +1 more source

Hepatoblastoma [PDF]

open access: yes, 2020
Michael Berger, Dietrich von Schweinitz
  +6 more sources

Home - About - Disclaimer - Privacy